Long-term outcome in adults with obsessive-compulsive disorder

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Obsessive-compulsive disorder (OCD) is a chronic mental health condition with significant long-term impact.
• Few studies have assessed long-term outcomes (over 5 years) in adult OCD patients, particularly with modern diagnostic and treatment standards.
• Existing data suggest variable long-term improvement rates (32-74%) but were gathered before validated scales and evidence-based treatments were widespread.

Purpose of the Study:

• To investigate the 10-20 year outcome of adult patients with obsessive-compulsive disorder (OCD).
• To examine the association between initial clinical characteristics and long-term OCD symptom severity.
• To determine if primary OCD symptom dimensions and initial response to serotonin reuptake inhibitor (SRI) pharmacotherapy predict later symptom severity.

Main Methods:

• A longitudinal study followed 83 adult OCD subjects for 10-20 years post-enrollment in placebo-controlled SRI trials.
• Clinical characteristics at initial assessment were analyzed for association with follow-up OCD symptom severity.
• Remission was defined as a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score of 8 or less.

Main Results:

• Only 20% of subjects achieved OCD remission (Y-BOCS ≤ 8) at long-term follow-up.
• Nearly half (49%) of participants continued to experience clinically significant OCD symptoms.
• Initial response to SRI pharmacotherapy was significantly linked to long-term outcome: 31% of initial responders remitted, versus 12% of partial responders and 0% of non-responders.
• No significant association was found between long-term outcome and specific OCD symptom dimensions.

Conclusions:

• Despite advances in evidence-based treatments for OCD, remission remains uncommon in adult patients.
• The initial response to pharmacotherapy with serotonin reuptake inhibitors (SRIs) is a critical predictor of long-term clinical outcomes in OCD.
• Further research may explore factors beyond initial SRI response influencing long-term OCD prognosis.